Sofregen
Cambridge, US · Founded 2014 · 8 employees on LinkedIn · 2 known investors
Sofregen develops silk protein-based biomaterials and medical devices for soft tissue regeneration in aesthetic and surgical procedures. The company creates injectable and implantable products designed to support tissue repair and enhancement in cosmetic and reconstructive surgery.
Founders & leadership
MK
Milan KofolNamed on SEC filing
DS
Doug SheldonNamed on SEC filing
AH
Anh HoangNamed on SEC filing
HW
Howard WeismanNamed on SEC filing
Board
AN
Amir Nashatin𝕏Board directorEntrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive roles
Investors · 2
Reported raises · per SEC filings
Form D private placements$17.8M disclosed across 2 rounds · 2016–2019
▶$8.1MraisedSep 2019 · 3 investors · BiotechnologyRule 506(b)
▶$8.1MraisedSep 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard WeismanExecutive Officer, Director
- Anh Hoang-LindsayDirector
- S. Douglas SheldonDirector
- Offering amount
- $8.1M
- Amount sold
- $8.1M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.7MraisedSep 2017 · 7 investors · BiotechnologyRule 506(b)
▶$9.7MraisedSep 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milan KofolExecutive Officer
- Doug SheldonDirector
- Anh HoangExecutive Officer
- Howard WeismanExecutive Officer, Director
- Amir NashatDirector
- Offering amount
- $9.7M
- Amount sold
- $9.7M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Sofregen do?
- Sofregen develops silk protein-based biomaterials and medical devices for soft tissue regeneration in aesthetic and surgical procedures. The company creates injectable and implantable products designed to support tissue repair and enhancement in cosmetic and reconstructive surgery.
- Who are Sofregen's investors?
- Sofregen's investors include Anzu Partners, Polaris Partners.
- How much funding has Sofregen raised?
- Sofregen has disclosed $17.8M raised across 2 rounds.
- Where is Sofregen headquartered?
- Sofregen is headquartered in Cambridge, US.